The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control
Open accessAbstract
OBJECTIVE: High-grade glioma (HGG) prognosis remains dismal, with inevitable, mostly local recurrence. Regimens for improving local tumor control are therefore needed. Photodynamic therapy (PDT) using porfimer sodium has been investigated but was abandoned due to side effects and lack of survival benefits. Intracellular porphyrins induced by 5-aminolevulinic acid (5-ALA) are approved for fluorescence-guided resections (FGRs), but are also photosensitizers. Activated by light, they generate reactive oxygen species with resultant cytotoxicity. The authors present a combined approach of 5-ALA FGR and PDT. METHODS: After 5-ALA FGR in recurrent HGG, laser diffusors were strategically positioned inside the resection cavity. PDT was applied for 60 minutes (635 nm, 200 mW/cm diffusor, for 1 hour) under continuous irrigation for maintaining optical clarity and ventilation with 100% oxygen. MRI was performed at 24 hours, 14 days, and every 3 months after surgery, including diffusion tensor imaging and apparent diffusion coefficient maps. RESULTS: Twenty patients were treated. One surgical site infection after treatment was noted at 6 months as the only adverse event. MRI revealed cytotoxic edema along resection margins in 16 (80%) of 20 cases, mostly annular around the cavity, corresponding to prior laser diffusor locations (mean volume 3.3 cm 3 ). Edema appeared selective for infiltrated tissue or nonresected enhancing tumor. At the 14-day follow-up, enhancement developed in former regions of edema, in some cases vanishing after 4–5 months. Median progression-free survival (PFS) was 6 months (95% CI 4.8–7.2 months). CONCLUSIONS: Combined 5-ALA FGR and PDT provides an innovative and safe method of local tumor control resulting in promising PFS. Further prospective studies are warranted to evaluate long-term therapeutic effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The use of ALA-PpIX as a fluorescent theranostic agent is well illustrated in a clinical trial where patients with recurrent glioblastoma underwent PpIX fluorescence-guided resection first followed immediately by PDT all after a single dose of ALA administration [165].”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [165]
In the citing paper
“Selective ALA-induced PpIX disposition in tumors made it possible for maximum safe resection of glioblastoma as well as targeting infiltrating tumor cells and unresectable tumor tissues in eloquent regions by PDT, resulting in promising progression-free survival in a disease with dismal prognosis.”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [165]
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J. F., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,890
Stummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., & Reulen, H.-J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70665-9 · Cited by 3,423
Self-citationA Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308573 · Cited by 2,834
HOW DOES PHOTODYNAMIC THERAPY WORK?
Henderson, B. W., & Dougherty, T. J. (1992) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1992.tb04222.x · Cited by 2,376
Photodynamic therapy with endogenous protoporphyrin
Kennedy, J. C., Pottier, R. H., & Pross, D. C. (1990) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(90)85083-9 · Cited by 1,509
Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials
Wong, E. T., Hess, K. R., Gleason, M. J., Jaeckle, K. A., Kyritsis, A. P., Prados, M. D., Levin, V. A., & Yung, W. K. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2572 · Cited by 902
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Desjardins, A., Gromeier, M., Herndon, J. E., Beaubier, N. T., Bolognesi, D. P., Friedman, A. H., Friedman, H. S., McSherry, F., Muscat, A. M., Nair, S. K., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716435 · Cited by 843
Castaño, A. P., Demidova, T. N., & Hamblin, M. R. (2005) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/s1572-1000(05)00030-x · Cited by 797
Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma
Wallner, K. E., Galicich, J. H., Krol, G. S., Arbit, E., & Malkin, M. G. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90941-3 · Cited by 785
Research works printed but not linked: 1
- Muller PJ, Wilson BC: A randomized two arm clinical trial of photophrin PDT and standard therapy in high grade gliomas—phase III trial, in Proceedings of the 6th International Symposium on Photodynamic Diagnosis and Therapy in Clinical Practice. Brixen/Bressanone, Italy, October 10–14, 2006
Cited by
Sorted by citations
Items 101–121 of 121
Letter to the Editor. A new approach for local tumor control
Menna, G., Olivi, A., & Pepa, G. M. D. (2021) · Journal of neurosurgery · doi:10.3171/2021.2.jns21409
(2021) · Reactions Weekly · doi:10.1007/s40278-021-94171-4
Laser illumination platform for real-time analytics and improvement of treatment efficacy
Kaivosoja, V., Perttilä, R., Kokko, E., Tanila, T., Ylöniemi, Z., & Uusimaa, P. (2022) · Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems · doi:10.1117/12.2608711
In-Vitro Use of Verteporfin for Photodynamic Therapy in GlioblastomaPreprint
Jeising, S., Geerling, G., Guthoff, R., Hänggi, D., Sabel, M. S., Rapp, M., & Nickel, A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4131174
Photodynamic therapy of malignant brain gliomas
Розуменко, В. Д., Liubich, L. D., Петровна, С. Л., Михайловна, Е. Д., Малышева, Т. А., & Dashchakovskyi, A. V. (2022) · Ukrainian Neurosurgical Journal · doi:10.25305/unj.263389
Zheng, P., Zhang, X., Ren, D., Bai, Q., & Jiang, P. (2023) · Neurology India · doi:10.4103/0028-3886.391381
Identification and Prognostic Value of m6A-Related Genes in Glioblastoma
Zheng, P., Zhang, X., Ren, D., & Bai, Q. (2024) · Neurology India · doi:10.4103/neurol-india.ni_1166_21
Alternative Splicing in Glioblastoma and its Clinical Implication in Outcome Prediction
Zheng, P., Zhang, X., Ren, D., & Bai, Q. (2024) · Neurology India · doi:10.4103/neurol-india.ni_1219_21
Phase-I/II-Studie zur radiodynamischen Therapie mit 5-ALA beim Glioblastomrezidiv
Pepper, N. B., Müther, M., Oertel, M., Rehn, S., Spille, D. C., Stummer, W., & Eich, H. T. (2025) · Forum · doi:10.1007/s12312-025-01423-3
Self-citationSkouras, P., Giakoumettis, G., Argyros, C., Vavoulis, G., Verigos, E. K., & Giakoumettis, D. (2025) · Pharmaceuticals · doi:10.3390/ph18030349
Kozlikina, E. I., Трифонов, И. С., Shakhmanaeva, A. U.-K., Sinkin, M. V., Krylov, V. V., Loschenov, V. B., & Levchenko, O. V. (2024) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2407-14
Sklyar, S. S., Sitovskaya, D., Ulitin, A., Sebelev, K. I., Андреев, Е. В., Nechaeva, A., Zorina, E. Y., Конова, А. М., Бакнина, А. К., Викторович, Д. М., et al. (2025) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2025-24-1-174-188
Cell cycle arrest and apoptosis in glioblastoma
Kulshrestha, S., Sharma, R., & Alexiou, A. T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33910-3.00008-x
Additional file 1 of Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
Mączyńska, J., Raes, F., Pieve, C. D., Turnock, S., Boult, J. K. R., Hoebart, J., Niedbała, M., Robinson, S. P., Harrington, K. J., Kaspera, W., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18849065
Михайлович, Р. Н., Polyakov, V. G., Kuzmina, N. E., Неизвестных, Е. А., & Kuzmina, A. V. (2026) · Biomedical Photonics · doi:10.24931/2413-9432-2025-14-4-34-42
Inhibiting glioma cell invasion by sequential photo-sonodynamic therapy
Laurel, S. R., Lee, T., Gulosino, R., Pok, E., Gupta, K., Wakida, N. M., & Hirschberg, H. (2026) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-026-00952-7
Михайлович, Р. Н., Polyakov, V. G., Kuzmina, N. E., Неизвестных, Е. А., Kuzmina, A. V., & Minko, M. A. (2026) · Ural Medical Journal · doi:10.52420/umj.25.3.7
Qiu, J. U. N. T. A. O., Li, Y., Zou, J., Wang, Y., Jü, R., & Guo, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27136091
5-Aminolevulinic Acid–mediated Photodynamic Therapy for Glioblastoma
Reyes, J. S., Bouras, A., Huq, S., Colán, J. A., Casillo, S. M., & Hadjipanayis, C. G. (2026) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2026.09.001
He, Z., Zhang, G., Wang, C., Wu, L., Hu, W., Duan, H., Chen, Y., Lu, J., Yuan, Z., Zhang, X., et al. (2026) · medRxiv · doi:10.64898/2026.10.07.26364687
Metadata
- Authors
- Schipmann, S., Müther, M., Stögbauer, L., Zimmer, S., Brokinkel, B., Holling, M., Grauer, O., Suero Molina, E., Warneke, N., & Stummer, W.
- Affiliations
- Department of Neurosurgery,
- Research Institute of Radiology (BY)
- University Hospital Münster (DE)
- Corresponding author
- Schipmann, Stephanie
- ORCID
- Venue
- Journal of Neurosurgery
- Published
- 2021-02
- Volume
- 134
- Issue
- 2
- Pages
- 426-436
- ISSN
- 0022-3085 (ISSN-L)
- 1933-0693
- OpenAlex
- W3001797168
- Cited by
- 121
- References
- 42
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 29 · 2023: 20 · 2022: 22 · 2021: 15
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of neurosurgery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Westfälische Wilhelms-Universität Münster
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- recurrent glioblastoma, 5-aminolevulinic acid, fluorescence-guided resection, photodynamic therapy, porphyrins, local tumor control, cytotoxic edema, progression-free survival, high-grade glioma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
